Cisplatin, the first metal-based chemotherapeutic drug, remains widely used despite its toxicity and the emergence of drug resistance. Combining Cisplatin with nanoparticles has been proposed to improve its therapeutic profile, although most studies rely on in vitro models. Here, we investigated the...
ORGANISM(S): Drosophila melanogaster